PIRAMAL ENTERPRISES LTD.

NSE : PELBSE : 500302ISIN CODE : INE140A01024Industry : Pharmaceuticals & DrugsHouse : Piramal Ajay
BSE1466.253.8 (+0.26 %)
PREV CLOSE ( ) 1462.45
OPEN PRICE ( ) 1464.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 78744
TODAY'S LOW / HIGH ( )1458.50 1484.05
52 WK LOW / HIGH ( )608 2001.25
NSE1467.355 (+0.34 %)
PREV CLOSE( ) 1462.35
OPEN PRICE ( ) 1462.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1467.35 (781)
VOLUME 677287
TODAY'S LOW / HIGH( ) 1455.65 1483.30
52 WK LOW / HIGH ( )606.85 2001.09
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-04 1947
Management Info
Ajay Piramal - Chairman - Managing Director
Registered Office

Address Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W ),
Mumbai,
Maharashtra-400070

Phone 022 3802 3000/4000

Email complianceofficer.phl@piramal.com

Website www.piramal.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
15Jul Piramal Group’s real estate arm introd
Piramal Group’s real estate arm-- Piramal Realty has introduced an onlin..
14Jul Piramal Enterprises informs about inte
In compliance with Regulation 57 of the Listing Regulations, Piramal Ent..
08Jul Reliance Industries, Bharti Airtel and
Reliance Industries’ wholly-owned subsidiary--Jio Platforms has received..
08Jul Piramal Enterprises raises Rs 76 crore
Piramal Enterprises has raised Rs 76 crore on private placement basis. T..
08Jul Piramal Enterprises gains on raising R
Piramal Enterprises is currently trading at Rs. 1431.70, up by 15.15 poi..
Financials
Rs. in Millions
QTR Jun 20 ANNUAL 20
Net Profit225.3999999999991448.5
Gross Profit 270.599999999999 5398.4
Operating Profit 3556.524253.6
Net Sales 8174.142191.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 2906.70 (4.25%)
M.Cap (Rs. in Cr)34753.96
NGL Fine-Chem (BSE)
 589.85 (20.00%)
M.Cap (Rs. in Cr)364.41
Glaxosmithkline Phar (BSE)
 1523.60 (4.51%)
M.Cap (Rs. in Cr)25810.70
Aarti Drugs (BSE)
 2139.65 (3.16%)
M.Cap (Rs. in Cr)4985.38
Caplin Point Lab (BSE)
 556.80 (9.10%)
M.Cap (Rs. in Cr)4211.79
Shareholding Pattern
PROMOTERS 46.06%
NON-INSTITUTION 14.52%
FI/BANKS/INSURANCE 8.76%
MUTUAL FUNDS/UTI 0.54%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Sanjay Jadli, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

For Lodge the grievances click on https://scores.gov.in

Click/visit on SEBI Complaints Redress System (SCORES) for Procedure for filing of complaints on SCORES and benefits.

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.